ST
AZN icon

SAL Trading’s AstraZeneca AZN Stock Holding History

SAL Trading’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39,351
Closed -$6.14M – 10
2024
Q2 		$6.14M Buy
39,351
+24,400
+163% +$3.67M 10.55% 2
2024
Q1 		$2.03M Buy
14,951
+4,801
+47% +$636K 2.31% 8
2023
Q4 		$1.37M Buy
10,150
+750
+8% +$97.5K 2.18% 14
2023
Q3 		$1.27M Buy
+9,400
New +$1.28M 1.78% 17
2023
Q1 		– Sell
-38,650
Closed -$5.24M – 44
2022
Q4 		$5.24M Sell
38,650
-39,500
-51% -$4.95M 3.05% 12
2022
Q3 		$8.57M Buy
78,150
+32,950
+73% +$4.18M 3.63% 7
2022
Q2 		$5.97M Buy
45,200
+27,350
+153% +$3.59M 2.53% 12
2022
Q1 		$2.37M Sell
17,850
-76,288
-81% -$9.15M 0.55% 25
2021
Q4 		$11M Buy
+94,138
New +$11.1M 4.47% 4

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SAL Trading's AZN Position: Q3 2024 in Review

SAL Trading sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 39,351 shares — an estimated $6.14M sold.

SAL Trading first reported a position in AZN in Q4 2021 and held it in 9 quarters. The position peaked at $11M in Q4 2021. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • SAL Trading reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
  • SAL Trading sold 39,351 AstraZeneca shares in Q3 2024, an estimated $6.14M.
  • SAL Trading first reported a position in AstraZeneca in Q4 2021 and held it in 9 quarters.
  • SAL Trading's AstraZeneca position peaked at $11M in Q4 2021.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on SAL Trading's 13F filing for Q3 2024, filed 14 Nov 2024.